- Received June 28, 2021
- Accepted October 30, 2021
- Publication November 13, 2021
- Visibility 1 Views
- Downloads 0 Downloads
- DOI 10.18231/j.jdp.2021.023
-
CrossMark
- Citation
COVID-19 and oral lesions: A review
- Author Details:
-
Vinay S Dua *
-
Amandeep Kaur
-
Ankit Sikri
-
Mitasha Sachdeva
Introduction
The first occurrence of a severe pulmonary illness of an unknown aetiology was reported in the city of Wuhan, China. The unfamiliar pathogen very soon progressed far and wide in Europe and then all over the world. The World health Organisation (WHO) in March 2020 formally announced a pandemic alert. [1], [2]
The virus
Initially, the virus was named as2019-nCoV. It waslatercalledas Sars-CoV-2, along with the severe acute respiratory syndrome (SARS-CoV) and the Middle East respiratory syndrome (MERS-CoV) viruses.[3] It was seen that this virus resides to the coronoviridae family. The term “coronavirus” is derivational of the Latin word CORONA meaning “Crown” due to its structural resemblance to a Crown with Multiple Spikes when were seen under an electron microscope.[4], [5] SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2)is a single-chain RNA virus; the cause of novel coronavirus disease hence it was named as COVID-19 by International Committee on Taxonomy of viruses(ICTV) on 11 February 2020.WHO also announced “COVID-19” as the name of this new disease on 11 February 2020. [1]
Transmission of virus and its manifestations
In general, the incubation period of Covid-19 ranges from 3 - 14 days. An incubation period of as long as 24-days has also been noted.[6] Direct contact and air borne infections are the main infection pathways. Droplets discharged by coughing, speech, exhalation or sneezing results in airborne infections. Direct contact on the contaminated areas and then touching mouth, nose or eyes results in direct contact infections of Covid-19.
Covid-19 diagnosis is established on the basis of clinical symptoms and epidemiological conditions. This includes patients who had history of any earlier contact with probably infected persons or who have travel history into the areas which have high number of Covid-19 infected individuals in the last 2 weeks before the onset of symptoms.[6] After the infection, the most commonly seen symptoms are dry cough, tiredness and fever. The symptoms which are comparatively less common are:-body aches and pain, headache, diarrhoea, sore throat, loss of sense of smell or taste, conjunctivitis or discoloration of fingers and toes or a rash on the skin. The relatively less common and severe symptoms are:- shortness of breath or difficulty in breathing, chest pressure or pain and very rarely loss of speech or movement.[7], [8] Anosmia (loss of smell) and/or ageusia (loss of taste) has been seen commonly in Covid – 19 infected individuals.
Oral manifestations
The patients who reported to dental office even at the pre-symptomatic stage presented with following symptoms: -hyposalivation, loss of taste and/or loss of smell (ageusia and/oranosmia). Other prevalent symptoms seen were:-erosion, macule, bulla, ulcer, pustule, plaque, depapillated tongue, papule, vesicle, halitosis, necrosis, whitish lesions, petechiae, erythema, spontaneous bleeding and haemorrhagic crust. In the descending order, the sites where the symptoms were seen were most commonly seen on tongue (38%), labial mucosa (26%), palate (22%), gingiva (8%), buccal mucosa (5%), oropharynx (4%), and least likely on tonsil (1%).
For the reported lesions; advocated diagnoses were candidiasis, aphthous stomatitis, vasculitis, drug eruption, Melkerson Rosenthal syndrome, herpetiformlesions, angina bullosa lesions, Kawasaki-like, Erythema multiforme like lesions, atypical sweet syndrome, angular cheilitis and necrotizing periodontal disease. [9]
Aphthous stomatitis
These lesions are commonly seen on the poorly, nonkeratinized and loosely attached areas of oral cavity. They mainly arise as multiple shallow ulcers with yellow-white pseudomembranous and with erythematous halos. In younger patients these lesions were observed without necrosis; whereas in older patients with immunosuppression and severe infection these lesions presented with necrosis and haemorrhagic crusts. Healing of the lesions was seen between 5 – 15 days. [10] The possible explanation for development of these lesions could be due to increased level of tumor necrosis factor (TNF)-α which can lead to chemotaxis of neutrophils to oral mucosa in Covid-19 patients. Other possible explanations for appearance of such lesions could be stress and immunosuppression secondary to COVID-19 infected individuals. [11]
Herpetiform/zosteriform lesions
These lesions are seen on both keratinized and nonkeratinized mucosae. These lesions present as multiple round yellowish-grey ulcers with an erythematous rim. These are usually unilateral and painful. The possible explanation for appearance of secondary herpetic gingivostomatitis is stress and immunosuppression associated with COVID-19 cases. [9], [11]
Ulcerative or erosive lesions
Such lesions are painful with irregularity in border which can be found on tongue, hard palate and labial mucoas.Covid-19 patients can develop ulcerative and erosive lesions due to drug eruption, vasculitis or thrombotic vasculopathy. [9], [11], [12], [13], [14]
Red and white patches or plaques
In Covid-19 patients, red and white plaques were seen on palate, dorsum of tongue and gingiva. The possible explanation for the appearance of these patches could be candidiasis due to long antibiotic treatment, deterioration of general status and oral hygiene. [9], [14]
Erythema multiformae like lesions
Such lesions comprise of erythematous macules, erosions, desquamative gingivitis, blisters and painful cheilitis with target lesions present in the extremities with haemorrhagic crust. The origin of these lesions comes in appearance on seventh day and remains up to twenty fourth day. [9], [15], [16]
Angina bullosa lesions
These lesions are usually asymptomatic and are often seen on hard palate and tongue. They appear as purple blisters without any random bleeding in them.
Melkerson rosenthal syndrome
It presents itself with lip swellings which are unilateral, tongue fissures, malaise and facial paralysis. The investigative data shows an increase CRP levels and ground gloss like opacities are seen in lungs during a CT scan. Once the treatment of Covid-19 is concluded, these symptoms are completely resolved. [17]
Kawasaki - like illness
Glossitis, swollen and erythematous tongue presented as red strawberry tongue and cheilitis are the oral lesions seen in COVID-19 patients with Kawasaki like disease. It is seen that a long period of intermission exists between onset of general symptoms (gastrointestinal or respiratory) and appearance of oral lesions. The possible reason could be attributed to a deferred hyperactive response of the immune system and secondary release of acute inflammatory cytokines instead of virus effecting directly on oral mucosa and skin. [18], [19], [20], [21], [22], [23]
Necrotizing periodontal disease
As per the case report of a lady of 35 years of age who presented with halitosis, fever, oral lesions and submandibular lymphadenopathy, it was doubtful that she was covid – 19 positive. On intraoral examination lesions inside the mouth were diffuse and painful, gums were oedematous and inter papillary areas were necrosed. All the signs were indicative of necrotizing periodontal disease which occurred due to bacterial coinfections existing along with covid 19 disease. These lesions were seen to recover after 5 days. [24]
Vesicles and pustules
A 51-year-old man had dry cough and anosmia, fatigue, fever, dysgeusia and covid-19 positive serology. Diffuse erythema was seen on the hard palate and oropharynx after 10 days, pustules were observed on the soft palate border. The diagnosis put forward was enanthema because of covid -19 and these lesions healed within days. [25]
Petechiae
Lower lip, palate and oro-pharynx mucosa were the noted sites for petechiae as reported in some studies. Petechiae were seen earlier as compared to macular lesions in patients exhibiting both these lesions. The suggested reason for Petechiae in COVID – 19 patients could bethrombocytopenia and the prescribed drugs. [25]
Nonspecific lesions (mucositis)
A number of studies noted Erythematous-violaceous plaques, papules, patches and macules on the tongue, lip mucosa, oropharynx and hard palate. The possible explanation for mucositis in COVID – 19 patients was thrombotic vasculopathy and vasculitis. [25], [26], [27]
Prevalence of taste disorders
The problems linked to the sense of smell and/or taste(anosmia and dysgeusia) are known as chemosensory disorders. Classification of taste disorders include qualitative or quantitative problems, of which dysgeusia (qualitative distortion of taste perception), hypogeusia (decreased sense of taste) and ageusia (absence of a sense of taste) are seen in covid-19 patients. [28]
A number of theories have been highlighted with respect to taste disorder pathogenesis in patients with COVID -19.In 2020, Finsterer and Stollberger[29] observed a localized inflammatory response originating from rhinitis. This response could hinder the normal functioning of taste buds; also due to nasal mucosal inflammation, the signs and symptoms observed do not necessarily indicate taste impairment in covid-19 cases. Many studies showed an increase in occurrence of taste disorders as compared to rhinorrhoea.
In another study performed in 2020 by Vaira, Salzano, Fois, et al., [30] stated that olfactory disorders associated with abnormal taste sensation may be detrimental for covid-19 patients.
Conclusion
In Covid-19 cases, oral symptoms are not very common. However taste alteration is one of the most common manifestation as observed by a small number of studies conducted till date. There is little proof regarding the etiopathogenesis and occurrence of oral lesions in Covid-19 cases.Covid-19 features a number of clinical conditions like immunity, impairment, coinfection and adverse reactions rather than fundamental oral mucosa infections.General practitionersare familiar with all the manifestations of SARS CoV-2 as these might be the sole symptoms present when the patients pays a visit to a dental clinic. The dental surgeon should follow all the prevailing preventive regulations; since they are in close contact with the patients which make them more prone to the dangerous Covid-19 infection.
Conflict of Interest
The authors declare that there are no conflicts of interest in this paper.
Source of Funding
None.
References
- . World Health Organization. 2020b. Health emergency dashboard WHO (COVID-19) homepage [accessed 2020 Aug 19]. . [Google Scholar]
- P Zhou, X L Yang, X G Wang, B Hu, L Zhang, W Zhang. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. [Google Scholar]
- N Chen, M Zhou, X Dong. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020. [Google Scholar] [Crossref]
- N Zhu, D Zhang, W Wang, X Li, B Yang, J Song. A novel coronavirus from patients with pneumonia in china. N Engl J Med 2019. [Google Scholar] [Crossref]
- J Lan, J Ge, J Yu, S Shan, H Zhou, S Fan. Structure of the sars‑cov‑2 spike receptor‑binding domain bound to the ace2 receptor. Nature 2020. [Google Scholar]
- M Balla, G P Merugu, M Patel. COVID - 19, modern pandemic: A systematic review from front - line health care provider’s perspective. J Clin Med Res 2020. [Google Scholar]
- . World Health Organization. Coronavirus Disease (covid-19) Pandemic. 2020. [Google Scholar]
- S Kar. Covid 19: A brief clinical overview. J Geriatr Care Res 2020. [Google Scholar]
- B Iranmanesh, M Khalili, R Amiri, H Zartab. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther 2021. [Google Scholar] [Crossref]
- T B Brandao, L A Gueiros, T S Melo. Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ?. Oral Surg Oral Med Oral Pathol Oral Radiol 2021. [Google Scholar]
- J A Dos Santos, A G Normando, R L Da Silva. Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?. Int J Infect Dis 2020. [Google Scholar]
- R Ansari, M Gheitani, F Heidari, F Heidari. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor. Oral Dis 2021. [Google Scholar]
- C Singh, J Tay, N Shoqirat. Skin and mucosal damage in patients diagnosed with COVID-19: a case report. J Wound Ostomy Continence Nurs 2020. [Google Scholar]
- J Corchuelo, F C Ulloa. Oral manifestations in a patient with a history of asymptomatic COVID-19. . Case Rep Int J Infect Dis 2020. [Google Scholar] [Crossref]
- J Jimenez-Cauhe, D Ortega-Quijano, I Carretero-Barrio. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clin Exp Dermatol 2020. [Google Scholar]
- P Labé, A Ly, C Sin. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol 2020. [Google Scholar]
- B Tas¸lıdere, L Mehmetaj, A B Özcan, B Gülen, N Tas¸lıdere. Melkersson-Rosenthal syndrome induced by COVID-19: a case report. Am J Emerg Med 2021. [Google Scholar]
- M Y Chérif, J M De Filette, S André, P Kamgang, B Richert, P Clevenbergh. Coronavirus disease 2019-related Kawasaki-like disease in an adult: a case report. JAAD Case Rep 2020. [Google Scholar]
- L Verdoni, A Mazza, A Gervasoni. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020. [Google Scholar]
- V G Jones, M Mills, D Suarez. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020. [Google Scholar]
- M Pouletty, C Borocco, N Ouldali. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort. Ann Rheum Dis 2020. [Google Scholar]
- K Chiotos, H Bassiri, E M Behrens. Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case series. J Pediat Infect Dis Soc 2020. [Google Scholar]
- J S Chiu, M Lahoud-Rahme, D Schaffer, A Cohen, M Samuels-Kalow. Kawasaki disease features and myocarditis in a patient with COVID19. Pediatr Cardiol 2020. [Google Scholar]
- J Patel, J Woolley. Necrotizing periodontal disease: oral manifestation of COVID-19. Oral Dis 2021. [Google Scholar]
- F Cebecikahraman, H Ças¸kurlu. Mucosal involvement in a COVID19-positive patient: a case report. Dermatol Ther 2009. [Google Scholar]
- J Jimenez-Cauhe, D Ortega-Quijano, D De Perosanz-Lobo. Enanthem in patients with COVID-19 and skin rash. JAMA Dermatol 2020. [Google Scholar]
- S Tomo, G I Miyahara, L E Simonato. Oral mucositis in a SARS-CoV2-infected patient: secondary or truly associated condition? . Oral Dis 2020. [Google Scholar] [Crossref]
- T Maheswaran, P Abikshyeet, G Sitra, S Gokulanathan, V Vaithiyanadane, S Jeelani. Gustatory dysfunction. J Pharm Bioallied Sci 2014. [Google Scholar]
- J Finsterer, C Stollberger. Causes of hypogeusia/hyposmia in SARSCoV2 infected patients. J Med Virol 2020. [Google Scholar]
- L A Vaira, G Salzano, M Petrocelli, G Deiana, F A Salzano, G De Riu, . Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck 2020. [Google Scholar] [Crossref]
- Introduction
- The virus
- Transmission of virus and its manifestations
- Oral manifestations
- Aphthous stomatitis
- Herpetiform/zosteriform lesions
- Ulcerative or erosive lesions
- Red and white patches or plaques
- Erythema multiformae like lesions
- Angina bullosa lesions
- Melkerson rosenthal syndrome
- Kawasaki - like illness
- Necrotizing periodontal disease
- Vesicles and pustules
- Petechiae
- Nonspecific lesions (mucositis)
- Prevalence of taste disorders
- Conclusion
- Conflict of Interest
- Source of Funding